LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $200,000 | -32.7% | 2,325 | -10.6% | 0.00% | -100.0% |
Q2 2019 | $297,000 | +12.9% | 2,602 | +24.4% | 0.00% | 0.0% |
Q1 2019 | $263,000 | -25.9% | 2,091 | +61.6% | 0.00% | -50.0% |
Q3 2018 | $355,000 | -1.7% | 1,294 | -25.7% | 0.00% | 0.0% |
Q2 2018 | $361,000 | +57.6% | 1,742 | +25.9% | 0.00% | +100.0% |
Q1 2018 | $229,000 | +11.2% | 1,384 | -19.7% | 0.00% | -50.0% |
Q2 2016 | $206,000 | -78.3% | 1,724 | -84.4% | 0.00% | -87.5% |
Q3 2015 | $949,000 | – | 11,083 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |